According to the study by Allagoa et al. (2021) from Yale School of Medicine found that screen-detected invasive cancers were more likely to be hormone receptor positive and smaller in size, consistent with our findings on tumor size distribution and ER/PR status. The gene discussed is ESR1; the disease is neoplasm.